Metastasis remains the primary challenge to reducing cancer deaths worldwide. A new MSK study is providing unique insights ...

The accelerated approval of Trodelvy for patients with metastatic urothelial cancer has been voluntarily withdrawn.

Metastasis remains the primary challenge to reducing cancer deaths worldwide. A study is providing insights that researchers say point to therapeutic opportunities.

Researchers determine whether artificial intelligence-based MRI data could predict prostate cancer patient outcomes.

A large-scale study links the presence of these tiny molecules to increased aggressiveness in malignant tumors ...

Metastatic breast cancer is a treatable yet complex stage IV condition. Advanced and targeted therapies, alongside open ...

Thomas Kraut, 59, was diagnosed as obese. After 12 years, a doctor finally realized that his rapidly growing belly actually ...

Scientists at the Johns Hopkins Kimmel Cancer Center have identified 16 genes that breast cancer cells use to survive in the ...

Using computational tools, researchers from the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins University School of ...

When treating brain metastases in patients with non–small cell lung cancer (NSCLC), brain radiotherapy has been the standard option. However, a growing body of evidence indicates that immunotherapy ...

The device, which disrupts cancer cell growth with electric fields, has shown improved survival rates in clinical trials with ...

A recent study offering a comprehensive view of the genome and transcriptome of gastrointestinal stromal tumors (GISTs) has introduced a new, multi-omics-based molecular classification of these tumors ...